Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Sep 1;88(17):7538-42.
doi: 10.1073/pnas.88.17.7538.

Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo

U H von Andrian  1 , J D Chambers, L M McEvoy, R F Bargatze, K E Arfors, E C Butcher
Affiliations

Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo

U H von Andrian et al. Proc Natl Acad Sci U S A. .

Abstract

The lectin homing receptor LECAM-1 (LAM-1, Leu8) and the beta 2 integrins, particularly Mac-1 (CD11b/CD18), participate in leukocyte-endothelial cell interactions in inflammation. LECAM-1 is rapidly shed while Mac-1 expression is dramatically increased upon neutrophil activation, suggesting functionally distinct roles for these molecules. Using intravital video microscopy, we have compared the effect of antibodies against LECAM-1 and CD18 on leukocyte interactions with rabbit mesenteric venules. Anti-LECAM-1 monoclonal antibody and its Fab fragments inhibited initial reversible leukocyte rolling along the vascular wall. Anti-CD18 monoclonal antibody had no effect on rolling but prevented subsequent firm attachment of leukocytes to venular endothelium. These results support a two-step model of leukocyte-endothelial cell interactions: reversible rolling mediated in part by LECAM-1 facilitates leukocyte recruitment by the local microenvironment and precedes activation-dependent firm attachment involving beta 2 integrins.

PubMed Disclaimer

References

    1. J Immunol Methods. 1987 Dec 24;105(2):211-20 - PubMed
    1. Blood. 1987 Jan;69(1):338-40 - PubMed
    1. J Cell Biol. 1990 Sep;111(3):1225-32 - PubMed
    1. Blood. 1990 Jul 1;76(1):178-83 - PubMed
    1. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2244-8 - PubMed

Publication types